Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the antitumor effect and safety of fludarabine
phosphate tablet in combination with rituximab in patient with indolent lymphoma.